NPM1 and anaplastic large cell lymphoma: Moreover, despite the fact that our assay can be applied to 95% of ALCL cases, expressing the NPM-ALK fusion transcript, patients bearing variant translocations, such as TPM3-ALK or ATIC-ALK cannot be analyzed using this NPM-ALK specific assay.